C4 Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 08/13/2026 | 8.87 M | $41.41 M | -2.26% | 7.03% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 8.00 M | $37.36 M | 0.00% | 6.35% |
| BLACKROCK, INC. | 08/07/2026 | 7.90 M | $36.88 M | 285.48% | 6.26% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 7.33 M | $34.22 M | 4.68% | 5.81% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 7.20 M | $33.62 M | 220.00% | 5.71% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/14/2026 | 7.17 M | $33.49 M | 0.00% | 5.69% |
| JPMORGAN CHASE & CO | 08/12/2026 | 4.75 M | $20.65 M | 47.30% | 3.77% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.42 M | $20.63 M | 14.39% | 3.50% |
| CITADEL ADVISORS LLC | 08/14/2026 | 4.19 M | $19.56 M | 66.77% | 3.32% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 3.53 M | $16.49 M | 47.90% | 2.80% |
| WASATCH ADVISORS LP | 07/10/2026 | 3.52 M | $16.45 M | 18.94% | 2.79% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 3.47 M | $16.20 M | 14.30% | 2.75% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 3.38 M | $15.78 M | -11.20% | 2.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 3.03 M | $14.16 M | 58.60% | 2.41% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 2.66 M | $12.41 M | 12.59% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.52 M | $11.78 M | 165.20% | 2.00% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 2.43 M | $11.36 M | 100.00% | 1.93% |
| STATE STREET CORP | 08/07/2026 | 2.12 M | $9.88 M | 452.42% | 1.68% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.81 M | $8.43 M | -4.48% | 1.43% |
| CANDRIAM S.C.A. | 08/13/2026 | 1.80 M | $8.38 M | 100.00% | 1.43% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.74 M | $8.13 M | 64.19% | 1.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.73 M | $8.09 M | 34.61% | 1.37% |
| PATIENT SQUARE CAPITAL LP | 08/12/2026 | 1.61 M | $7.51 M | 100.00% | 1.28% |
| HIGHVISTA STRATEGIES LLC | 08/14/2026 | 1.35 M | $6.30 M | 100.00% | 1.07% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.19 M | $5.56 M | -51.67% | 0.94% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.19 M | $5.55 M | 168.58% | 0.94% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.16 M | $5.42 M | 512.49% | 0.92% |
| CONGRESS ASSET MANAGEMENT CO /MA | 07/07/2026 | 1.00 M | $4.69 M | 20.81% | 0.80% |
| FMR LLC | 08/13/2026 | 894.05 K | $4.18 M | 228.25% | 0.71% |
| UBS GROUP AG | 08/13/2026 | 828.97 K | $3.87 M | 284.00% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 781.06 K | $3.65 M | 72.71% | 0.62% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 781.06 K | $3.65 M | 100.00% | 0.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 736.33 K | $3.44 M | 100.00% | 0.58% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 680.09 K | $3.18 M | 100.00% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 609.15 K | $2.84 M | 25.82% | 0.48% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/14/2026 | 580.20 K | $2.71 M | 1,121.28% | 0.46% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 570.00 K | $2.66 M | 100.00% | 0.45% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 523.65 K | $2.45 M | 15.54% | 0.42% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 495.82 K | $2.32 M | 100.00% | 0.39% |
| NUVEEN, LLC | 08/11/2026 | 484.01 K | $2.26 M | 100.00% | 0.38% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 452.70 K | $2.11 M | -47.84% | 0.36% |
| MAN GROUP PLC | 08/14/2026 | 408.65 K | $1.91 M | 59.34% | 0.32% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 400.00 K | $1.87 M | 100.00% | 0.32% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 08/13/2026 | 384.77 K | $1.80 M | 0.00% | 0.31% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 381.17 K | $1.78 M | 567.83% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 370.55 K | $1.73 M | -50.73% | 0.29% |
| ATOM INVESTORS LP | 08/14/2026 | 364.35 K | $1.70 M | 167.81% | 0.29% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 335.08 K | $1.56 M | 28.74% | 0.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 325.00 K | $1.52 M | 100.00% | 0.26% |
| JANE STREET GROUP, LLC | 08/14/2026 | 302.75 K | $1.41 M | -75.72% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
C4 Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 192 institutional investors and hedge funds held shares of C4 Therapeutics Inc. The most heavily invested institutionals were:
MORGAN STANLEY: 8.87 M
RA CAPITAL MANAGEMENT, L.P.: 8 M
BlackRock, Inc.: 7.9 M
Lynx1 Capital Management LP: 7.33 M
Squadron Capital Management LLC: 7.2 M
Bain Capital Life Sciences Investors, LLC: 7.17 M
93.99% of C4 Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 129.75 M shares in the last 24 months. This purchase volume represents approximately $465.79 M in transactions.